Funding for this research was provided by:
Japan Society for the Promotion of Science (25221002, 26293213, 26460309)
Text and Data Mining valid from 2020-01-17
Received: 26 October 2018
Accepted: 8 November 2019
First Online: 17 January 2020
: S.M. owns equity in a gene therapy company (Gene Therapy Research Institution, Co., Ltd.) that commercialises the use of AAV vectors for gene-therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, S.M. has a conflict of interest. H.K. and K.M. have submitted a patent related to this work. H.K will own equity in a future therapeutic company using the STAND method. As such, H.K. has a conflict of interest. The remaining authors declare no competing interests.